Document is current
Any future updates will be listed below
-
Authors
Salvatori, Silvia
Frascatani, Rachele
De Vico, Pasquale
Marafini, Irene
Monteleone, Giovanni
-
Funding
Funding for this research was provided by:
Università degli Studi di Roma Tor Vergata
- License Information
-
More Information
Article History
Received: 23 April 2026
Revised: 16 June 2026
Accepted: 1 July 2026
First Online: 11 July 2026
Declarations
:
: Giovanni Monteleone served as a consultant for First Wave BioPharma and Giuliani SpA and as a speaker for Takeda, Eli Lilly, Abbvie, Galapagos, and Pfizer and filed a patent related to the treatment of inflammatory bowel diseases with Smad7 antisense oligonu-cleotides. Irene Marafini served as a consultant and speaker for Abbvie, Eli Lilly and Galapagos.
